Published in Pulm Circ on June 01, 2014
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine. Nat Rev Cardiol (2016) 1.13
Role of homocysteine in the development of cardiovascular disease. Nutr J (2015) 1.12
Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease. Hypertension (2014) 0.83
Epigenetic Modifications in Essential Hypertension. Int J Mol Sci (2016) 0.77
TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H2S System. Front Pharmacol (2017) 0.75
Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells. J Cancer Res Clin Oncol (2016) 0.75
Translating the histone code. Science (2001) 56.77
Chromatin modifications and their function. Cell (2007) 55.98
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A (2005) 15.46
Stability and flexibility of epigenetic gene regulation in mammalian development. Nature (2007) 14.57
Histone demethylation by a family of JmjC domain-containing proteins. Nature (2005) 10.36
Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell (2011) 9.16
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature (2005) 8.53
Sirtuins in mammals: insights into their biological function. Biochem J (2007) 7.60
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell (1992) 7.11
Histones: annotating chromatin. Annu Rev Genet (2009) 5.93
DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol (2004) 4.96
Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol (2006) 4.93
MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A (2008) 4.16
Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem (2000) 2.60
Role for miR-204 in human pulmonary arterial hypertension. J Exp Med (2011) 2.60
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med (2012) 2.59
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation (2012) 2.54
Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol (2005) 2.52
Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet (2003) 2.39
Grand challenge commentary: RNA epigenetics? Nat Chem Biol (2010) 2.33
Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development (2012) 2.24
RNA nucleotide methylation. Wiley Interdiscip Rev RNA (2011) 2.15
Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation (2010) 2.06
Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res (2006) 1.99
Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol (2011) 1.98
PIWI-interacting RNAs: from generation to transgenerational epigenetics. Nat Rev Genet (2013) 1.92
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation (2012) 1.75
Long noncoding RNAs in cardiac development and pathophysiology. Circ Res (2012) 1.72
Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest (2007) 1.65
Catalysis and substrate selection by histone/protein lysine acetyltransferases. Curr Opin Struct Biol (2008) 1.64
A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res (2012) 1.61
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. Int J Cardiol (2013) 1.56
The control of histone lysine methylation in epigenetic regulation. Biochimie (2006) 1.48
Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism. Circ Res (2012) 1.37
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med (2011) 1.37
Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood (2007) 1.31
Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med (2013) 1.30
Nuclear architecture and gene regulation. Biochim Biophys Acta (2008) 1.23
Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation (2011) 1.20
Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med (2011) 1.19
HDAC4 controls histone methylation in response to elevated cardiac load. J Clin Invest (2013) 1.15
Project set to map marks on genome. Nature (2010) 1.13
Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc. Cardiovasc Res (2011) 1.04
The role of redox signaling in epigenetics and cardiovascular disease. Antioxid Redox Signal (2013) 1.03
Holding our breath: The emerging and anticipated roles of microRNA in pulmonary hypertension. Pulm Circ (2012) 1.01
Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells. Trends Biochem Sci (2009) 0.99
Epigenetic modifications of stem cells: a paradigm for the control of cardiac progenitor cells. Circ Res (2011) 0.98
Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms? Circulation (2012) 0.90
Epigenetic regulation of cardiac development and function by polycomb group and trithorax group proteins. Dev Dyn (2012) 0.82